Literature DB >> 33627642

SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity.

Nicolas Huot1, Philippe Rascle1,2, Caroline Petitdemange1, Vanessa Contreras3, Christina M Stürzel4, Eduard Baquero5, Justin L Harper6, Caroline Passaes1, Rachel Legendre7, Hugo Varet8, Yoann Madec9, Ulrike Sauermann10, Christiane Stahl-Hennig10, Jacob Nattermann11, Asier Saez-Cirion1, Roger Le Grand3, R Keith Reeves12, Mirko Paiardini6,13, Frank Kirchhoff4, Beatrice Jacquelin1, Michaela Müller-Trutwin14.   

Abstract

Natural killer (NK) cells play a critical understudied role during HIV infection in tissues. In a natural host of SIV, the African green monkey (AGM), NK cells mediate a strong control of SIVagm infection in secondary lymphoid tissues. We demonstrate that SIVagm infection induces the expansion of terminally differentiated NKG2alow NK cells in secondary lymphoid organs displaying an adaptive transcriptional profile and increased MHC-E-restricted cytotoxicity in response to SIV Env peptides while expressing little IFN-γ. Such NK cell differentiation was lacking in SIVmac-infected macaques. Adaptive NK cells displayed no increased NKG2C expression. This study reveals a previously unknown profile of NK cell adaptation to a viral infection, thus accelerating strategies toward NK-cell directed therapies and viral control in tissues.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33627642      PMCID: PMC7904927          DOI: 10.1038/s41467-021-21402-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  94 in total

1.  Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.

Authors:  Morten Nielsen; Claus Lundegaard; Peder Worning; Sanne Lise Lauemøller; Kasper Lamberth; Søren Buus; Søren Brunak; Ole Lund
Journal:  Protein Sci       Date:  2003-05       Impact factor: 6.725

2.  Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers.

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Bioinformatics       Date:  2008-04-14       Impact factor: 6.937

3.  Protein structure modeling with MODELLER.

Authors:  Benjamin Webb; Andrej Sali
Journal:  Methods Mol Biol       Date:  2014

4.  CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

Authors:  Vivien Béziat; Olav Dalgard; Tarik Asselah; Philippe Halfon; Pierre Bedossa; Ali Boudifa; Baptiste Hervier; Ioannis Theodorou; Michelle Martinot; Patrice Debré; Niklas K Björkström; Karl-Johan Malmberg; Patrick Marcellin; Vincent Vieillard
Journal:  Eur J Immunol       Date:  2011-12-16       Impact factor: 5.532

5.  Human Adaptive Natural Killer Cells: Beyond NKG2C.

Authors:  Julia A Wagner; Todd A Fehniger
Journal:  Trends Immunol       Date:  2016-05-11       Impact factor: 16.687

6.  Spotlight on NKG2C and the human NK-cell response to CMV infection.

Authors:  Karl-Johan Malmberg; Vivien Beziat; Hans-Gustaf Ljunggren
Journal:  Eur J Immunol       Date:  2012-12       Impact factor: 5.532

Review 7.  NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.

Authors:  G Alter; M Altfeld
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

Review 8.  Tissue reservoirs of HIV.

Authors:  Joseph K Wong; Steven A Yukl
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

9.  Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.

Authors:  Veron Ramsuran; Vivek Naranbhai; Amir Horowitz; Ying Qi; Maureen P Martin; Yuko Yuki; Xiaojiang Gao; Victoria Walker-Sperling; Gregory Q Del Prete; Douglas K Schneider; Jeffrey D Lifson; Jacques Fellay; Steven G Deeks; Jeffrey N Martin; James J Goedert; Steven M Wolinsky; Nelson L Michael; Gregory D Kirk; Susan Buchbinder; David Haas; Thumbi Ndung'u; Philip Goulder; Peter Parham; Bruce D Walker; Jonathan M Carlson; Mary Carrington
Journal:  Science       Date:  2018-01-04       Impact factor: 47.728

Review 10.  A Natural Impact: NK Cells at the Intersection of Cancer and HIV Disease.

Authors:  Olivier Lucar; R Keith Reeves; Stephanie Jost
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

View more
  8 in total

1.  NK cell spatial dynamics and IgA responses in gut-associated lymphoid tissues during SIV infections.

Authors:  Philippe Rascle; Cyril Planchais; Béatrice Jacquelin; Marie Lazzerini; Vanessa Contreras; Caroline Passaes; Asier Saez-Cirion; Hugo Mouquet; Nicolas Huot; Michaela Müller-Trutwin
Journal:  Commun Biol       Date:  2022-07-07

2.  Adaptive MHC-E restricted tissue-resident NK cells are associated with persistent low antigen load in alveolar macrophages after SARS-CoV-2 infection.

Authors:  Nicolas Huot; Cyril Planchais; Vanessa Contreras; Beatrice Jacquelin; Caroline Petitdemange; Marie Lazzerini; Pierre Rosenbaum; Félix Rey; R Keith Reeves; Roger Le Grand; Hugo Mouquet; Michaela Müller-Trutwin
Journal:  Res Sq       Date:  2022-04-25

3.  IL-21 and IFNα therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques.

Authors:  Justin Harper; Nicolas Huot; Michaela Müller-Trutwin; Mirko Paiardini; Luca Micci; Gregory Tharp; Colin King; Philippe Rascle; Neeta Shenvi; Hong Wang; Cristin Galardi; Amit A Upadhyay; Francois Villinger; Jeffrey Lifson; Guido Silvestri; Kirk Easley; Beatrice Jacquelin; Steven Bosinger
Journal:  Nat Commun       Date:  2021-05-17       Impact factor: 14.919

Review 4.  So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Authors:  Adam J Kleinman; Ivona Pandrea; Cristian Apetrei
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

5.  An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.

Authors:  Vinicius A Vieira; Emily Adland; David F G Malone; Maureen P Martin; Andreas Groll; M Azim Ansari; Maria C Garcia-Guerrero; Mari C Puertas; Maximilian Muenchhoff; Claudia Fortuny Guash; Christian Brander; Javier Martinez-Picado; Alasdair Bamford; Gareth Tudor-Williams; Thumbi Ndung'u; Bruce D Walker; Veron Ramsuran; John Frater; Pieter Jooste; Dimitra Peppa; Mary Carrington; Philip J R Goulder
Journal:  PLoS Pathog       Date:  2021-11-18       Impact factor: 6.823

6.  Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.

Authors:  Opeyemi S Adeniji; Leticia Kuri-Cervantes; Chenfei Yu; Ziyang Xu; Michelle Ho; Glen M Chew; Cecilia Shikuma; Costin Tomescu; Ashley F George; Nadia R Roan; Lishomwa C Ndhlovu; Qin Liu; Kar Muthumani; David B Weiner; Michael R Betts; Han Xiao; Mohamed Abdel-Mohsen
Journal:  PLoS Pathog       Date:  2021-11-11       Impact factor: 7.464

7.  Limited impact of fingolimod treatment during the initial weeks of ART in SIV-infected rhesus macaques.

Authors:  Maria Pino; Amélie Pagliuzza; M Betina Pampena; Claire Deleage; Elise G Viox; Kevin Nguyen; Inbo Shim; Adam Zhang; Justin L Harper; Sadia Samer; Colin T King; Barbara Cervasi; Kiran P Gill; Stephanie Ehnert; Sherrie M Jean; Michael L Freeman; Jeffrey D Lifson; Deanna Kulpa; Michael R Betts; Nicolas Chomont; Michael M Lederman; Mirko Paiardini
Journal:  Nat Commun       Date:  2022-08-27       Impact factor: 17.694

8.  CD32+CD4+ T Cells Sharing B Cell Properties Increase With Simian Immunodeficiency Virus Replication in Lymphoid Tissues.

Authors:  Nicolas Huot; Philippe Rascle; Cyril Planchais; Vanessa Contreras; Caroline Passaes; Roger Le Grand; Anne-Sophie Beignon; Etienne Kornobis; Rachel Legendre; Hugo Varet; Asier Saez-Cirion; Hugo Mouquet; Beatrice Jacquelin; Michaela Müller-Trutwin
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.